Clinical Trial Update: Pulmozyme in Cystic Fibrosis With Sinusitis [Phase 3]

View source ↗

Summary

Phase 3 trial of Pulmozyme for cystic fibrosis with sinusitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Sinusitis

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Sinusitis, Cystic Fibrosis | Phase 3 | Status: WITHDRAWN